AI Summary Cabometyx (cabozantinib) is a once-daily oral tyrosine kinase inhibitor used for advanced hepatocellular carcinoma previously treated with sorafenib.
Medically reviewed.
Cabometyx (cabozantinib) is a prescription targeted therapy used to treat advanced hepatocellular carcinoma (HCC), kidney cancer, and thyroid cancer. It belongs to a class of medications called tyrosine kinase inhibitors (TKIs), which work by blocking signals involved in tumor growth, metastasis, and blood vessel formation. In liver cancer, it is used for advanced HCC that was previously treated with sorafenib. Treatment decisions should always be individualized and guided by a healthcare professional.
This page covers Cabometyx's role in liver cancer management — how it works, who may be eligible, benefits, side effects, and monitoring. You can also connect with a liver specialist near you for personalized guidance on whether Cabometyx fits your care plan.
Liver Health AI Assistant
Ask Aimy
Aimy answers from LiverDirectory’s reviewed health information — helping patients make sense of liver-health terms, prepare for specialist visits, and explore what to look up next.
ABOUT CABOMETYX TREATMENT
Cabometyx is a prescription medicine that contains cabozantinib, a type of medication known as a tyrosine kinase inhibitor (TKI). It works by blocking signals that drive tumor growth, the spread of cancer (metastasis), and the formation of new blood vessels that feed a tumor.
Cabometyx is used to treat advanced hepatocellular carcinoma (HCC), kidney cancer, and thyroid cancer. In liver cancer, it is used for advanced HCC that has already been treated with sorafenib (Nexavar) and that needs systemic treatment, meaning medicine that travels through the whole body.
It is typically used as long-term therapy, alongside regular monitoring by your healthcare provider, such as Liver Function Tests (LFTs) and blood pressure checks.
WHO CABOMETYX MAY BE SUITABLE FOR
Eligibility for Cabometyx depends on your diagnosis, your earlier treatment, and your individual health needs. Your healthcare provider may prescribe it if you have advanced hepatocellular carcinoma that was previously treated with sorafenib, and your liver cancer needs systemic treatment.
It may also be considered when you need a second-line treatment option for advanced HCC, when you are a candidate for targeted therapy, or when your provider wants to slow cancer progression.
Because every patient's health profile is different, there is no one-size-fits-all answer to who should take Cabometyx. Treatment decisions are individualized and should be made by a qualified healthcare professional after a full assessment of your liver condition and treatment goals.
ELIGIBILITY OVERVIEW
Cabometyx may be considered for adults with the following conditions or treatment goals:
Before recommending Cabometyx, healthcare providers evaluate several factors to determine whether it is an appropriate option, including:
HOW CABOMETYX CAN HELP YOUR LIVER
Cabometyx blocks several tyrosine kinases, which are proteins that help cancer cells grow and survive. Blocking them reduces cancer cell survival and spread.
It also inhibits angiogenesis, the formation of new blood vessels inside a tumor. Tumors need these vessels to grow, so limiting them helps slow tumor progression.
For people with advanced HCC, these actions can help control the disease. Cabometyx is not used alone: your provider pairs it with regular monitoring, such as Liver Function Tests (LFTs), blood pressure checks, and tracking of how the cancer responds.
LIVER CANCER BENEFITS
Tyrosine kinases are proteins that send signals inside cells. In cancer, some of these signals help tumor cells grow, survive, and spread. Cabometyx blocks several tyrosine kinases involved in cancer growth. This reduces cancer cell survival and spread, which is why it is called a targeted therapy.
Cabometyx also inhibits angiogenesis, the formation of new blood vessels in a tumor. Tumors rely on these vessels for their blood supply. By limiting tumor blood vessel formation, Cabometyx works on the tumor's supply line as well as on the cancer cells themselves.
Together, these two actions help slow tumor progression. For people with advanced hepatocellular carcinoma (HCC), slowing progression is a main goal of treatment. Individual responses vary, and your healthcare provider tracks how your cancer responds over time.
Cabometyx helps control advanced liver cancer as part of a long-term treatment plan. It is taken daily and continued for as long as it is working and you tolerate it. Regular checks of liver function, blood pressure, and treatment response help your care team decide whether it is still the right option for you.
Cabometyx blocks cancer growth signals and tumor blood vessel formation to help control advanced HCC. It should only be started and monitored under the guidance of a qualified healthcare professional.
TREATMENT PROCESS
Cabometyx is supplied as an oral tablet. Take it exactly as prescribed by your healthcare provider.
The usual dose for hepatocellular carcinoma is 60 mg once daily. Your healthcare provider determines the right dose for you.
Take Cabometyx on an empty stomach, at least 1 hour before or 2 hours after eating. Always use it exactly as your healthcare provider directs.
Cabometyx is used as long-term systemic therapy in advanced liver cancer. It is continued until the disease progresses or side effects become unacceptable. Treatment length is individualized based on your response and how well you tolerate it.
Store Cabometyx at room temperature, away from moisture and heat.
Regular monitoring of liver function, blood pressure, and treatment response is recommended. Report any side effects or unusual symptoms to your healthcare provider.
BENEFITS AND SAFETY
Cabometyx (cabozantinib) may support people with advanced hepatocellular carcinoma by blocking pathways involved in tumor growth and spread and by reducing the formation of blood vessels in tumors. This helps delay progression and control the disease. The extent of these benefits varies from person to person, depending on liver condition, earlier treatment, and how the body responds to therapy.
Cabometyx works as part of a broader, personalized care plan that includes regular monitoring, such as Liver Function Tests (LFTs), blood pressure checks, and assessment of treatment response.
As with any medication, Cabometyx may cause side effects. Your healthcare provider will monitor your treatment and assess whether Cabometyx remains a suitable option for you.
BENEFITS
Cabometyx blocks pathways involved in tumor growth and spread. Instead of acting only on one signal, it blocks several tyrosine kinases that cancer cells use to grow and survive.
Cabometyx helps delay progression of advanced HCC. For many people, keeping the disease from advancing is the main aim of long-term treatment. How much benefit you get depends on your liver condition, your earlier treatment, and how your body responds.
Cabometyx reduces tumor blood vessel formation. Angiogenesis is the growth of new blood vessels, and limiting it works against the tumor's blood supply.
Cabometyx is a convenient oral treatment. It comes as a tablet taken once a day, on an empty stomach, so you can take it at home as prescribed.
Your healthcare provider will discuss the potential benefits and risks before treatment and provide ongoing support, including monitoring of liver function and blood pressure. Report severe or persistent symptoms promptly.
SUPPORTING YOUR RESULTS
Lifestyle habits are an important part of care alongside Cabometyx. Good hydration and nutrition, paced activity to manage fatigue, early treatment of diarrhea, regular skin and foot care, and home blood pressure checks can all help.
These habits can help you manage common side effects and stay well during long-term treatment. Ask your healthcare provider which steps fit your situation.
Areas that may support treatment:
common questions
Cabometyx is used to treat advanced hepatocellular carcinoma (HCC) that has already been treated with sorafenib and needs systemic treatment, meaning medicine that travels through the whole body. The medicine, which contains cabozantinib, is also used for kidney cancer and thyroid cancer. It is a tyrosine kinase inhibitor, a type of targeted therapy that blocks signals involved in tumor growth, spread, and blood vessel formation. Your healthcare provider can explain whether it fits your care plan.
Your healthcare provider may prescribe Cabometyx if you have advanced hepatocellular carcinoma previously treated with sorafenib, or if your liver cancer needs systemic treatment. It may also be considered when you need a second-line option, you are a candidate for targeted therapy, or your provider wants to slow cancer progression. Eligibility depends on your diagnosis, earlier treatment, and overall health, so there is no one-size-fits-all answer. Ask a liver specialist whether Cabometyx is appropriate for you.
Take Cabometyx exactly as your healthcare provider prescribes. It comes as an oral tablet. The usual dose for hepatocellular carcinoma is 60 mg once daily, taken on an empty stomach, at least 1 hour before or 2 hours after eating. Store the tablets at room temperature, away from moisture and heat. Your provider determines the right dose for you, so do not change how you take it without asking them first.
The common side effects of Cabometyx are fatigue, diarrhea, hand-foot skin reaction, decreased appetite, and high blood pressure. Your healthcare provider will monitor your liver function and blood pressure during treatment. Report severe or persistent symptoms promptly. Treating diarrhea early, caring for your skin and feet regularly, and checking your blood pressure at home can help, so ask your care team what to watch for.
No. Cabometyx is used to help control advanced liver cancer, not as a cure. It blocks signals that drive tumor growth and limits tumor blood vessel formation, which helps delay progression. How much benefit you get varies with your liver condition, earlier treatment, and response to therapy. Talk with your healthcare provider about realistic goals and how your response will be tracked.
It depends on how your cancer responds and how well you tolerate the medicine. Cabometyx is used as long-term systemic therapy for advanced liver cancer. It is continued until the disease progresses or side effects become unacceptable. Your healthcare provider individualizes the length of treatment based on your response and tolerability. Ask your provider how often you will be checked and what would prompt a change in your plan.
Medical disclaimer: LiverDirectory provides educational information and a directory of providers. It does not provide medical advice, diagnosis, or treatment. Always consult a licensed physician regarding any medical condition.
